|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities | |||||
| Depreciation | |||||
| Amortization | |||||
| Amortization of debt discount | |||||
| Impairment of goodwill and intangible assets | |||||
| Shares Issued for Services | |||||
| Shares Issued as gift | |||||
| Stock based compensation expense | |||||
| Financing cost | |||||
| Change in fair value of derivative financial instruments | |||||
| Shares issued for loan and interest | |||||
| Loss on conversion of convertible note to common stock | |||||
| Loss on exercise of warrants | |||||
| Changes in assets and liabilities | |||||
| Right of use lease asset | |||||
| Accounts payable | |||||
| Prepaid expenses | |||||
| Payroll payable | |||||
| Accrued interest | |||||
| Lease liability | |||||
| Due to related party | |||||
| Net cash used in operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Acquisition of software | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Proceeds from the issuance of common shares for cash | |||||
| Shares to be issued for cash | |||||
| Promissory Note | |||||
| Proceeds from issuance of preferred stock | |||||
| Proceeds from issuance of convertible notes | |||||
| Proceeds from issuance of promissory notes | |||||
| Repayment of promissory notes | |||||
| Net cash provided by financing activities | |||||
| Net Increase in Cash | |||||
| Cash at beginning of year | |||||
| Cash at end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid during the period for interest | |||||
| Cash paid during the period for income tax | |||||
| Schedule of non-cash investing and financing activities: | |||||
| Reversal of Warrants | |||||
| Contingent equity consideration issued in acquisition | |||||
| Conversion of contingent equity consideration payable to equity | |||||
| Conversion of Series A Preferred Stock to Class A Common Stock | |||||
| Conversion of convertible debt to equity | |||||
| Recognition of operating lease: right of use asset and lease liability | |||||
| Fair value of warrants issued as deferred offering cost | |||||
| Fair value of convertible debt beneficial conversion feature allocated to proceeds of debt | |||||
| Fair value of warrants allocated to proceeds of debt | |||||
| Fair value of common shares allocated to proceeds of debt | |||||
| Deferred offering costs payable in stock | |||||
| Contingent equity consideration payable from acquisition | |||||
| Forgiveness of accrued payroll | |||||
| Shares issued for conversion of notes | |||||
Loading...